Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STA-5326 in Crohn's Disease
NCT00250198Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apilimod in Crohn's disease, sponsored by National Institute of Allergy and Infectious Diseases. Started Nov 2005; status: completed.
02
Drugs
apilimod
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00250198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00250198.